Free Trial

Tenet Healthcare (THC) Projected to Post Quarterly Earnings on Thursday

Tenet Healthcare logo with Medical background

Tenet Healthcare (NYSE:THC - Get Free Report) will likely be announcing its earnings results before the market opens on Thursday, February 13th. Analysts expect the company to announce earnings of $2.95 per share for the quarter. Parties interested in registering for the company's conference call can do so using this link.

Tenet Healthcare Stock Performance

Shares of THC stock traded up $0.83 during mid-day trading on Friday, reaching $140.63. The stock had a trading volume of 689,247 shares, compared to its average volume of 951,949. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 2.35. Tenet Healthcare has a 1-year low of $86.70 and a 1-year high of $171.20. The firm has a market cap of $13.37 billion, a price-to-earnings ratio of 4.51, a PEG ratio of 0.63 and a beta of 2.05. The business's fifty day moving average is $133.96 and its 200-day moving average is $148.69.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. StockNews.com lowered shares of Tenet Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, December 17th. Truist Financial decreased their target price on shares of Tenet Healthcare from $190.00 to $175.00 and set a "buy" rating for the company in a research report on Monday, January 6th. UBS Group lifted their price objective on Tenet Healthcare from $197.00 to $217.00 and gave the company a "buy" rating in a research note on Wednesday, October 30th. The Goldman Sachs Group lowered Tenet Healthcare from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $196.00 to $140.00 in a report on Monday, December 16th. Finally, Royal Bank of Canada upped their price objective on Tenet Healthcare from $174.00 to $183.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 30th. Three equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $165.00.

Get Our Latest Stock Analysis on THC

Tenet Healthcare Company Profile

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Read More

Earnings History for Tenet Healthcare (NYSE:THC)

Should You Invest $1,000 in Tenet Healthcare Right Now?

Before you consider Tenet Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.

While Tenet Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines